Ilomedin 20

Ilomedin 20

iloprost

Manufacturer:

Bayer

Distributor:

Zuellig
/
Four Star
Concise Prescribing Info
Contents
Iloprost trometamol
Indications/Uses
Advanced thromboangiitis obliterans (Buerger's disease) w/ critical limb ischemia in cases where revascularization is not indicated. Severe peripheral arterial occlusive disease (PAOD), particularly those patients at risk of amputation & in whom surgery or angioplasty is not possible. Severe disabling Raynaud's phenomenon unresponsive to other therapies.
Dosage/Direction for Use
Adjust dose according to individual tolerability w/in 0.5-2 ng/kg/min over 6 hr daily by IV infusion for up to 4 wk. First 2-3 days: 0.5 ng/kg/min over 30 min. Duration of treatment for Raynaud's phenomenon: 3-5 days.
Contraindications
Hypersensitivity. Conditions which might increase risk of hemorrhage eg, active peptic ulcer, trauma, intracranial hemorrhage. Severe CHD or unstable angina; MI w/in previous 6 mth; acute or chronic CHF (NYHA II-IV); severe arrhythmias; suspected pulmonary congestion. Pregnancy & lactation.
Special Precautions
Surgery should not be delayed in patients requiring urgent amputation (eg, infected gangrene). Smoking cessation is recommended. Use cautiously in patients w/ low BP; significant heart disease; CVA (eg, transient ischemic attack, stroke) w/in the last 3 mth. Risk of orthostatic hypotension. Oral ingestion & mucous membrane contact must be avoided; long-lasting but painless erythema upon skin contact. Hepatic dysfunction & renal failure requiring dialysis. Adolescents & childn.
Adverse Reactions
Headache; flushing; nausea, vomiting; hyperhidrosis.
Drug Interactions
Additive antihypertensive activity of β-blockers, Ca antagonists & vasodilators. Potentiated antihypertensive activity of ACE inhibitors. Increased risk of bleeding w/ heparin or coumarin-type anticoagulants. Additive or superadditive platelet aggregation effects w/ acetylsalicylic acid or other NSAIDs, phosphodiesterase inhibitors & nitrovasodilators (eg, molsidomine).
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)
ATC Classification
B01AC11 - iloprost ; Belongs to the class of platelet aggregation inhibitors excluding heparin. Used in the treatment of thrombosis.
Presentation/Packing
Form
Ilomedin 20 inj 20 mcg/mL
Packing/Price
5 × 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in